Dipl.-Medienwirt (FH) Matthias Back ♥ Process Worldwide

Dipl.-Medienwirt (FH) Matthias Back

Process Developer
Vogel Communications Group

Articles of the author

With the format "China Market Insider" PROCESS Worldwide regularly reports on the Chinese chemical and pharmaceutical market. (©sezerozger - stock.adobe.com)
China Market Insider

New PTA Production Plant into Operation

Hengli Petrochemical started up the world's largest stand-alone pure terephthalic acid (PTA) production plant at the end of June. According to PROCESS China, the new PTA-5 plant has an annual capacity of 2.5 million tons and is ready to be the third new plant to be started up in China this year.

Read on
 (Picture: BASF)
Top 10 Chemical Companies

BASF the Undisputed Leader in the TOP 10 Chemical Company Rankings

The leading chemical companies in the world come from Germany and the US: BASF with a turnover of 73.5 billion euros in 2011 was well ahead of US-based Dow Chemical which had a turnover of 46.28 billion euros. Nevertheless, BASF only came 71st in Fortune magazine’s rankings of the world's major corporations. Currently, no company from the emerging economies of India, China or Brazil made it intoi the Top-10---

Read on
Johnson & Johnson had a workforce of around 128,000 in 60 countries worldwide. The company had 800 employees in Germany at sites in Neuss (330) and Wuppertal and at regional offices. Corporate headquarters in New Brunswick NJ, USA is shown in the photo. (Picture: Johson & Johnson)
Johnson & Johnson, Novartis, et al

Top 10 Pharmaceutical Companies by Revenue

An unprecedented acquisition battle is currently being waged in the pharmaceutical industry. Pfizer has launched an 85.2 million euro bid for Astra Zeneca, and Valeant has upped its takeover offer for Botox maker Allergan to $47 billion. Bayer has gone even further and has reported the $14.2 billion takeover of Merck’s over-the-counter drugs business. The time has come for PROCESS to take a closer look.

Read on
This steamcracker in Nanjing, PR China, is a joint–venture project of BASF and Sinopec with a total investment of US $ 2.9 billion. (Picture: BASF)
ACHEMA 2012: Trend Report Plant Engineering

Plant Engineering Between Individual Solutions and Container Modules

Market and raw material trends set the direction in the chemical industry. That is one of the reasons why the 2008/2009 crisis signaled the start of a paradigm shift in chemical plant engineering and construction. Traditional EPC suppliers (general contractors based in the Western industrialized nations) are facing increased competition from Asia. At the same time, the plant engineering teams at global chemical companies are intensifying their partnerships with EPCs and spreading the workload across the international engineering resource base.

Read on
 (© Paulista/Fotolia.com)
Smart Solutions for Smart Minds

What Will the Future of the Laboratory Look Like?

The modern laboratory environment is shaped by the same trends that affect most areas of today’s life: Flexibility, digitalization, communication — combined with the never-changing requirements for a lab such as safety, robustness, and cleanliness. In our article you will read more about the changes in hardware and software over the years and what the future of the laboratory might look like.

Read on
Ellen Kullmann submitted her resignation as chairman of the US-based chemical company Dupont on 16th October 2015. (Picture: Dupont)
Dupont

Shocking News: Kullmann Resigned from the US-Based Chemical Company Dupont

The chairman of the US-based chemical company Dupont Ellen Kullmann has surprisingly submitted her resignation on 16th October 2015. For the time being, the company affaires are managed by Edward Breen with its head office in Wilmington, Delaware/USA. Different media speculate the resignation as a consequence of the current savings program and the correction of profits forecast for 2015.

Read on
 (Picture: apops/Fotolia)
Pharma Deals, Acquisitions and Takeover

Top 10 Pharma–Deals: The Biggest Fusions of a 265 Billion Dollar Market

The pharma sector is under extreme pressure: For years now, turnover and profits for the pharma giants have been declining. Given the tightening situations on global markets, takeovers and fusions are a frequently attempted way out of the plight. According to a study by Ernst & Young, the pharma industry is on the brink of mergers and buy-overs to the sum of 265 billion dollars, in 2014. PharmaTEC summarises the biggest deals to date in the sector.

Read on
BASF’s Nutrition & Health division to focus on growth and increased competitiveness. (Picture: BASF)
Corporate Growth

BASF’s Nutrition & Health Division Renews its Focus

BASF is implementing a series of measures within the Nutrition & Health division to strengthen the competitiveness of its Performance Products segment. The Nutrition & Health division bundles BASF’s products and solutions for human and animal nutrition, the flavor and fragrance industry as well as the pharmaceutical industry.

Read on
 (Bild: Bayer/Peter Ginter)
Business Development

Bayer Starts Very Successfully into 2014

The Bayer Group started the year 2014 with encouraging growth in sales and earnings. Health Care experienced strong growth thanks to the gratifying development in sales of the recently launched pharmaceutical products. Crop Science benefited from an early start to the season in Europe. Material Science, in particular, raised earnings substantially.

Read on